LinkedIn-USA,ASIA,CANADA-urn:li:share:7341117712774897665
The LeAAPS Trial is underway and evaluating left atrial appendage exclusion (LAAE) to prevent ischemic stroke in high-risk cardiac surgery patients without a history of Afib. This groundbreaking research aims to elevate patient care standards by validating LAAE's effectiveness using AtriClip devices.
Learn more about LeAAPS: <a href="https://okt.to/MIl4Gs" target="_blank">https://okt.to/MIl4Gs</a>
